Huvepharma N.V. Sustainability Profile
Huvepharma N.V., a leading global player in the pharmaceutical industry, is headquartered in the Netherlands (NL) and operates extensively across Europe, North America, and Asia. Founded in 2001, the company has established itself as a key provider of innovative animal health products, focusing on the development and manufacturing of veterinary pharmaceuticals and nutritional solutions. With a diverse portfolio that includes antibiotics, vaccines, and feed additives, Huvepharma is renowned for its commitment to quality and efficacy. The company’s unique approach combines advanced research with a deep understanding of animal health needs, positioning it as a trusted partner in the livestock and aquaculture sectors. Notable achievements include significant market share growth and a reputation for excellence in product development, solidifying Huvepharma's status as a leader in the animal health market.
DitchCarbon Score
How does Huvepharma N.V.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Huvepharma N.V.'s score of 23 is lower than 69% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Huvepharma N.V.'s reported carbon emissions
Huvepharma N.V., headquartered in the Netherlands (NL), currently does not have specific carbon emissions data available, as indicated by the absence of reported emissions figures. The company is classified as a current subsidiary and does not inherit emissions data from a parent organization. In terms of climate commitments, there are no documented reduction targets or initiatives such as Science-Based Targets (SBTi) or other climate pledges. This lack of data suggests that Huvepharma N.V. may still be in the early stages of developing a comprehensive climate strategy or reporting framework. As the industry increasingly prioritises sustainability, it is essential for Huvepharma N.V. to establish clear emissions reduction goals and engage in climate initiatives to align with global standards and expectations.
How Carbon Intensive is Huvepharma N.V.'s Industry?
How Carbon Intensive is Huvepharma N.V.'s Location?
Huvepharma N.V.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Huvepharma N.V. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
